A monthly deep dive into the most influential and practice-shaping publications in Gastroenterology. Each episode breaks down key studies, highlights clinical implications, and offers clear, evidence-based insights for busy clinicians, trainees, and researchers. Whether it’s landmark trials, emerging therapies, or updated guidelines, this podcast brings the latest GI literature to life—helping listeners stay current, think critically, and apply new knowledge at the bedside.

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/3/24/19/24e17135-cbd7-439f-bb0c-f55a3633cdac_predicting_liver_failure_before_damage_shows.m4a

This study evaluates how effectively a specific blood biomarker, phosphatidylethanol (PEth), can forecast severe liver complications in individuals at risk for alcohol-related liver disease. While traditional noninvasive tests primarily measure existing liver scarring or fibrosis, this research demonstrates that tracking PEth levels provides a distinct, independent layer of prognostic data regarding a patient&#39;s future health. Although the predictive accuracy of a single PEth measurement fades over time, the study highlights that monitoring changes in alcohol intakethrough repeated testing is a powerful tool for identifying those most likely to experience hepatic failure. Ultimately, the findings suggest that integrating this chemical marker with standard physical assessments offers a more comprehensive view of disease progression than using either method in isolation.

Gastroenterology April 2026 Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/3/24/18/f6d016ad-8869-40bd-898f-268aa2a70120_your_dna_predicts_ibd_surgery_risk.m4a

This study investigates whether a person’s inherited predisposition to inflammatory bowel disease (IBD) also determines how aggressively the condition will progress. By analyzing thousands of patients, researchers found that individuals with a higher genetic burden faced significantly more hospitalizations, surgeries, and a greater need for intensive drug therapies. While the severity of Crohn’s disease was often linked to how much of the digestive tract was affected, ulcerative colitis showed a more direct shared genetic architecture between developing the disease and experiencing its most debilitating symptoms. Ultimately, the findings suggest that the same DNA markers used to predict the risk of IBD can also serve as a vital tool for forecasting a patient&#39;s long-term clinical outcome.

Gastroenterology April 2026 Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course Severity

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/3/24/18/a962a006-9561-4d74-a701-36b39a25bec2_how_gut_bacteria_rewire_your_immunity.m4a

This study explores how a common gut bacterium, Faecalibacterium prausnitzii, protects human health by directly influencing immune cells to reduce inflammation. Researchers discovered that this specific microbe triggers a dose-dependent production of IL10, a vital anti-inflammatory signal, within monocytes located in both the blood and the intestines. Unlike other bacteria, F. prausnitzii achieves this effect by rewiring the metabolic pathways of these cells, specifically by shifting their reliance toward mitochondrial respiration. By providing a mechanistic explanation for how this bacterium stabilizes the immune system, the text highlights its potential as a therapeutic tool for treating inflammatory bowel disease

Gastroenterology April 2026 Faecalibacterium prausnitzii Induces an Anti-inflammatory Response and a Metabolic Reprogramming in Human Monocytes

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/3/5/17/6e0cce8c-13b9-44d8-9c66-87207f0d7fdf_anemia_signals_precancerous_gastric_lesions.m4a

This study investigates the medical correlation between iron deficiency anemia and the development of gastric intestinal metaplasia, a condition considered a precursor to stomach cancer. By examining a cohort of patients infected with H. pylori, researchers discovered that those suffering from low iron were significantly more likely to exhibit these precancerous lesions. The risk was particularly pronounced in patients with persistent infections who failed previous treatments, showing a four-fold increase in the likelihood of tissue changes. Ultimately, the findings advocate for enhanced endoscopic monitoring and tissue sampling in anemic patients to ensure early detection and better clinical outcomes.

Gastro Hep Advances March 2026 Iron Deficiency Anemia Is Associated With Gastric Intestinal Metaplasia in Patients With Helicobacter pylori Infection

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/2/27/18/55fa1790-7bdd-434c-a7cd-e293a6324cec__somatic_mutations_drive_unexplained_polyposis.m4a

This research investigates the genetic origins of colorectal polyps in patients who lack a known hereditary diagnosis for their condition. By analyzing the somatic mutations and molecular signatures of nearly 300 tumors, the study highlights how specific genetic drivers like APC and BRAF distinguish different types of growths. A key discovery is that serrated polyps appear molecularly closer to healthy colon tissue than other tumor types, suggesting a distinct developmental pathway. Ultimately, this work seeks to clarify the early stages of tumor formation to better understand the underlying disease causes in patients with unexplained polyposis.

Gastroenterology March 2026 Mutational Landscape of Colorectal Tumors From Individuals With Unexplained Adenomatous or Serrated Colorectal Polyposis

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/2/27/17/986d7188-85f6-4af2-8b77-7ac385511103_h.m4a

This research utilizes CRISPR-Cas9 gene-editing technology to identify specific genes that normally prevent the development of stomach cancer. By testing thousands of potential targets within mouse-derived organoids, the researchers discovered that the loss of genes like Pten and those in the TGF-ß pathway significantly accelerates tumor growth and creates early-stage cancer lesions. The study further explores how the environment surrounding a tumor changes, noting that the presence of Helicobacter pylori does not alter genetic mutations but instead recruits immune cells that promote tumor progression. Ultimately, this work establishes a versatile experimental model that mimics human disease, allowing scientists to better understand the complex relationship between genetics and external risk factors in gastric carcinogenesis.

Gastroenterology February 2026  Gastric Organoid-Based Ectopic and Orthotopic In Vivo CRISPR Screening for Tumor Suppressors in Gastric Cancer

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/2/27/16/6db02d47-fce1-4742-82b4-1a6494cb5860_thirteen_life-saving_rules_for_inpatient_ibd.m4a

The American Gastroenterological Association developed these guidelines to standardize the complex care required for adults hospitalized with severe inflammatory bowel disease. By addressing thirteen critical clinical areas, the text provides a framework for prompt evaluation, ranging from the use of biomarkers and endoscopy to the proactive prevention of venous thromboembolism. The recommendations emphasize a multidisciplinary approach that balances aggressive medical treatments, such as intravenous corticosteroids, with timely surgical consultations for high-risk complications. Ultimately, the source aims to reduce hospital-acquired issues and readmission rates by ensuring treatment stability and a clear transition plan are established before a patient is discharged.

Gastroenterology February 2026 AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review Description

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/2/25/19/86f91642-4811-4af0-8018-aedfd1512882_abolic_solutions_for_the_silent_liver_epidemic.m4a

This study highlights a critical gap in global health policy, as liver diseases like MASLD and MASH are currently missing from the World Health Organization’s primary strategies for non-communicable diseases. By surveying hundreds of international experts, the research establishes a strong global consensus on fifteen essential interventions that should be prioritized for their high impact and feasibility. The findings emphasize that managing obesity and type 2 diabetes is the most effective long-term strategy, while routine fibrosis screening offers the most immediate public health benefit. Ultimately, the text serves as a strategic roadmap for policymakers, urging them to integrate liver health into broader health agendas to better combat the rising tide of chronic disease.

Lancet February 2026  Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/2/25/19/950e7d3a-f1df-442e-8177-ef4ceb3139ac_ic_liquid_diet_beats_daily_crohn_s_maintenance.m4a

This research study investigated whether specialized liquid diets could successfully maintain long-term clinical remission in children with Crohn&#39;s disease without the need for traditional pharmaceutical drugs. Researchers compared two distinct methods: a cyclic approach involving two-week bursts of an exclusive liquid diet every two months, and a partial approachwhere patients consumed a small portion of their daily calories as liquid formula alongside regular food. The results demonstrated that the cyclic method was significantly more effective at preventing disease relapses over the course of a year. By prioritizing nutritional intervention over medication, this trial highlights a promising dietary strategy for managing pediatric illness while avoiding the potential side effects associated with long-term drug use.

Lancet February 2026  Cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain long-term drug-free remission in paediatric Crohn's disease (CD-HOPE): an open-label, endpoint-blinded, randomised controlled trial

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/2/25/17/fd531d0d-7e33-446f-ab62-7605212592c3_endix_surgery_beats_jak_inhibitors_for_colitis.m4a

This study investigated whether surgical removal of the appendix could help patients with severe ulcerative colitis who no longer respond to standard biological medications. By comparing this procedure to the alternative of switching to JAK inhibitor drugs, researchers found that patients who underwent an appendicectomy were significantly more likely to achieve long-term clinical remission. Beyond merely reducing symptoms, the surgical approach also showed superior results in healing the intestinal lining compared to the medical switch. Ultimately, the findings suggest that appendicectomy is a safe and effective supplemental treatment for managing refractory cases of this chronic inflammatory condition.

Lancet February 2026 Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort study

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/2/12/20/b51170f3-8c64-4196-b2f0-30a38ced9679_ge_barriers_delayed_cancer_screening_two_years.m4a

This research study investigates whether broadening Medicaid eligibilityto include low-income adults regardless of their immigration status helps improve preventative healthcare outcomes. By comparing patients in states that adopted these inclusive policies against those that did not, the authors found a significant increase in colorectal cancer screenings among various Latino and Latina subgroups. These findings highlight that eliminating insurance barriers is a vital strategy for addressing health disparities, as cancer remains a primary cause of mortality within these communities. Ultimately, the text suggests that state-funded coverage expansions serve as an effective tool for boosting life-saving medical checkups among historically underserved populations.

JAMA February 2026 Prevalence of Colorectal Cancer Screening Among Latino Adults Following the Medicaid Eligibility Amendment Expansion

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/2/10/1/7395c9cf-dbc0-47af-80b5-624e4fe30642_alectin-4_sabotages_liver_cancer_immunotherapy.m4a

This research investigates why most liver cancer patients fail to respond to standard combined immunotherapy, identifying a protein called galectin-4as a primary culprit behind treatment resistance. By stabilizing metabolic enzymes and triggering specific chemical signals, galectin-4 forces the tumor into a state of metabolic adaptation that effectively shields it from the immune system. This process creates a hostile environment that neutralizes protective T cells while attracting suppressive cells that prevent the therapy from working. Ultimately, the study suggests that measuring galectin-4 levels can predict patient outcomes, and blocking this protein may provide a vital strategy for restoring the effectiveness of life-saving cancer treatments.

BMJ Gut February 2026:Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/2/10/0/78b3f1d1-30b3-4437-89fb-62706f6a65fc_standardizing_fecal_transplant_donor_screening.m4a

To address the lack of uniform evidence-based standards, this article proposes a rationalized framework for screening stool donors to ensure the safety of fecal microbiota transplants. The authors conducted a comparative review of existing guidelines and utilized an expert Delphi process to balance the prevention of pathogen transmission with the need to maintain an adequate donor supply. By advocating for increased transparency and rigorous record-keeping, the text emphasizes a structured approach to tracking donor health and procedural outcomes. Ultimately, the research aims to modernize clinical practices by integrating emerging metagenomic technologies to better identify potential risks and streamline the donor selection process.

BMJ GUT February 2026:Towards optimising and standardising donor screening for faecal microbiota transplantion.

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/2/5/21/5f49762e-32fd-4831-a658-bc99e3463881_izumab_for_severe_pediatric_ulcerative_colitis.m4a

The SHINE-1 study explored the potential of mirikizumab, a specialized antibody treatment, for children and adolescents suffering from moderate-to-severe ulcerative colitis who had failed previous therapies. By blocking a specific inflammatory protein known as IL-23, the drug aimed to reduce intestinal damage and provide long-term relief through a sequence of intravenous and subcutaneous doses. The findings revealed that a significant portion of young patients achieved clinical and endoscopic remission by the end of the year-long trial, often without the need for steroids or surgery. While some participants experienced mild side effects like headaches or injection site pain, the overall safety and efficacy results suggest that this treatment is a promising alternative for pediatric patients facing difficult-to-manage bowel disease.

Lancet Gastroenterology Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial.Background

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/1/28/22/b6a9ea2d-d649-45f7-9922-8735ad7a56a2_treating_appendicitis_with_antibiotics.m4a

This long-term clinical study evaluates whether treating uncomplicated appendicitis with medication is a viable alternative to traditional surgery over a ten-year period. By tracking hundreds of patients, researchers found that while nearly 40% of those who took antibiotics eventually experienced a recurrence, the majority avoided surgery entirely without sacrificing their overall quality of life. Notably, the group treated with antibiotics suffered significantly fewer medical complications than those who underwent an appendectomy. These findings suggest that for many adults, a non-surgical approach is a safe and effective primary option for managing this common condition.

JAMA Gastroenterology January 2026:Antibiotic Therapy for Uncomplicated Acute Appendicitis: Ten-Year Follow-Up of the APPAC Randomized Clinical Trial

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/1/28/22/1aa0f8fb-36a1-4487-87b7-acbbd87ef8ad_gut_pain_fuels_restrictive_eating.m4a

This population-based study investigates the strong correlation between disorders of gut-brain interaction (DGBI) and avoidant/restrictive food intake disorder (ARFID) among the general adult population in the United Kingdom and United States. The researchers discovered that individuals suffering from digestive issues are significantly more likely to restrict their food intake, with the risk of disordered eating rising as the anatomic regions affected by gut issues increase. Beyond simple dietary avoidance, the presence of both conditions leads to a higher overall health burden, including psychological distress, lower quality of life, and increased medical costs. Ultimately, the text advocates for integrated clinical screening to ensure that patients receive comprehensive care from a combined team of medical and mental health professionals.

Gastroenterology February 2026: The Prevalence and Burden of Avoidant/Restrictive Food Intake Disorder Symptoms in Adults With Disorders of Gut-Brain Interaction: A Population-Based Study

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/1/28/22/40035002-5b6f-4bba-9b5d-6fdc0bc3f553_eradicating_h.m4a

While health policies often focus on the link between Helicobacter pylori and stomach cancer, this research highlights the massive global burden of other conditions caused by the bacteria, such as peptic ulcers and indigestion. By analyzing international data, the authors demonstrate that eradicating the infection could prevent millions of cases of illness, suggesting that current medical guidelines significantly underestimate the total clinical advantagesof mass screening. The study concludes that future health assessments must include these secondary benefits to accurately reflect the true value and cost-effectiveness of widespread treatment programs.

Gastroenterology February 2026:The Disease Burden of Helicobacter pylori Beyond Gastric Cancer

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/1/18/19/d3ff8c8a-9fe1-4901-9bde-270fcf191f48_gallbladder_surgery_risks_change_with_age.m4a

This nationwide Swedish study investigated the long-term survival rates of nearly 160,000 patients who underwent gallbladder removal surgery over several decades. By comparing these patients to the general public, researchers discovered a distinct age-based disparity in mortality outcomes following the procedure. While older patients generally experienced lower mortality, those who had the surgery between the ages of 20 and 39 faced a higher risk of death, often linked to lifestyle factors like smoking and alcohol consumption. Ultimately, the research suggests that while cholecystectomy is generally safe, the underlying health and habitsof younger patients may play a critical role in their long-term recovery and lifespan.

Clinical Gastroenterology and Hepatology; January 2026  Long-Term Mortality After Cholecystectomy in a Nationwide Cohort of Swedish Individuals Between 1969 and 2016

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/1/18/19/da4d9a6e-4ff5-45f4-97bc-3193484ea947_winning_the_h.m4a

This comprehensive study evaluates the success rates of various antibiotic combinations used to eliminate H. pylori infections within a diverse American population. The research highlights that four-drug regimens, specifically concomitant and bismuth-based quadruple therapies, serve as the most effective initial treatments and maintain their potency over time. Crucially, the data suggests that prior antibiotic exposure and the repetition of failed drug cycles significantly diminish success, particularly during secondary &#34;salvage&#34; attempts. Ultimately, the authors advocate for a personalized prescribing strategy that avoids redundant medications and carefully considers a patient&#39;s medical history to overcome bacterial resistance.

Clinical Gastroenterology and Hepatology; January 2026 Comparative Effectiveness of Empiric Treatment for Helicobacter pylori in a Large, Diverse Population in the United States

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2026/1/18/13/c2ccd250-b36a-43b6-acc3-0dfcb3778e63_botox_cures_the_inability_to_burp.m4a

This research investigates Retrograde Cricopharyngeus Dysfunction (R-CPD), a condition where the throat muscle fails to relax, making it impossible for a person to belch. By using advanced pressure-sensing technology during a sparkling water provocation test, scientists discovered that patients with this disorder maintain excessively high pressure in the upper esophageal sphincter, causing gas to become trapped or oscillate painfully in the esophagus. The study confirms that botulinum toxin injections effectively lower this pressure, allowing for successful air clearance and symptom relief. Ultimately, the paper establishes specific manometric benchmarks that allow doctors to accurately diagnose and treat this frequently overlooked digestive issue.

Clinical Gastroenterology and Hepatology; January 2026 Diagnosis of Retrograde Cricopharyngeus Dysfunction Using High Resolution Impedance Manometry and Comparison With Control Subjects

A monthly deep dive into the most influential and practice-shaping publications in Gastroenterology. Each episode breaks down key studies, highlights clinical implications, and offers clear, evidence-based insights for busy clinicians, trainees, and researchers. Whether it’s landmark trials, emerging therapies, or updated guidelines, this podcast brings the latest GI literature to life—helping listeners stay current, think critically, and apply new knowledge at the bedside.